VKTX

NASD Viking Therapeutics, Inc.
Nov 1, 2026 · 3:41 PM ET EOD Market Closed

$27.28 ↑ +0.00 (+0.00%) Trading Up from the previous close of $27.28, $0.55 below the day’s high of $27.83

YTD change
-22.46%
vs 20-day SMA
+1.97%
vs 200-day SMA
-15.90%

Price ranges

Previous day
$26.31 $27.83
open $26.77 close $27.28
+$0.51 (+1.91%)
Today
$26.31 $27.83
$27.28
Past week
$23.82 $27.76
from $25.83 now $27.28
+$1.45 (+5.61%)
Past month
$23.82 $31.09
from $30.51 now $27.28
-$3.23 (-10.59%)
This year
$23.82 $43.10
from $35.18 now $27.28
-$7.90 (-22.46%)

Price & Performance

-2.72 (-9.07%) / 6M

$22.78$29.71$36.63$43.56May 1Aug 3Oct 30

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 72.6% away from all-time highs of $99.41
  • VKTX is down 22% since the beginning of the year
  • VKTX is down 29% over the past 12 months
  • VKTX is down 11% over the past 1 month
  • 21% of all VKTX investors are betting against VKTX

VKTX reads neutral: price sits above one of the two key moving averages, the 12-month move is -24.2%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-1.55
Earnings momentum +18.9% Quarterly EPS growth
Quarterly change +18.9%

Valuation

P/E ratio N/A
Enterprise value $2.5B
Beta 2.39

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$959.8M
Debt$254.7K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $3.5B

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $466.01 +1.15%
MRNA Moderna, Inc. $221.72 -0.47%
RVMD Revolution Medicines, Inc. $191.31 +0.55%
ROIV Roivant Sciences Ltd. $36.91 -1.63%
BNTX BioNTech SE Sponsored ADR $88.17 -1.08%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.